Abbott Laboratories (NYSE:ABT) Updates FY25 Earnings Guidance

Abbott Laboratories (NYSE:ABT – Get Free Report) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $5.05-$5.25 for the period, compared to the consensus earnings per share estimate of $5.16. Abbott Laboratories also updated its FY 2025 guidance to 5.050-5.250 EPS. Abbott Laboratories Stock Up […]

Leave a Reply

Your email address will not be published.

Abbott Laboratories (NYSE:ABT) Updates FY25 Earnings Guidance

Abbott Laboratories (NYSE:ABT – Get Free Report) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $5.05-$5.25 for the period, compared to the consensus earnings per share estimate of $5.16. Abbott Laboratories also updated its FY 2025 guidance to 5.050-5.250 EPS. Abbott Laboratories Stock Up […]

Leave a Reply

Your email address will not be published.

Previous post Trump’s perceived enemies worry about losing pensions, getting audited and paying steep legal bills
Next post Phoenix Copper (LON:PXC) Trading 22.2% Higher – Here’s What Happened